MLH1 rs1800795: Understanding This Promoter Variant
The rs1800795 variant is a single-nucleotide polymorphism located in the promoter region of the MLH1 gene. It is studied for its potential to influence gene expression levels and its association with an increased risk for cancers related to Lynch syndrome.
What each genotype means
Lower IL-6 expression
This genotype is associated with lower production levels of the interleukin-6 (IL-6) cytokine compared to the G allele. Research suggests this may correlate with different inflammatory responses, though clinical significance varies by context. Please discuss any health concerns or inflammatory conditions with your healthcare provider.
This genotype is common in populations of European ancestry but is rare in African and East Asian populations, where the G allele is nearly universal.
Intermediate IL-6 expression
Carrying one copy of each allele results in an intermediate level of IL-6 production compared to the homozygous genotypes. This variation influences how your body may regulate inflammatory markers like C-reactive protein. Consult with your clinician if you have questions regarding how this might relate to your personal health history.
This heterozygous genotype is frequently observed in European populations and is less common in other global populations.
Higher IL-6 expression
This genotype is associated with higher baseline levels of the IL-6 cytokine. Some studies have linked this variant to an increased risk for certain metabolic conditions, such as type 2 diabetes, particularly in elderly populations. Because these associations are statistical and not diagnostic, please discuss your overall health and any specific risks with your doctor.
This is the most common genotype globally, and it is nearly fixed in many African and East Asian populations.
What is rs1800795?
The variant rs1800795 is a specific change in the DNA sequence located within the promoter region of the MLH1 gene. A promoter is a regulatory segment of DNA that acts like a switch, determining when and how much of a gene's instructions are used to create proteins. Because this variant sits in a critical control area, researchers investigate whether it alters the efficiency of the MLH1 gene's activity. Unlike variants that change the protein structure itself, promoter variants like rs1800795 are primarily examined for their impact on the quantity of protein produced by the cell. Understanding these regulatory changes is a key part of modern genomics, as they can influence how our bodies maintain cellular health and repair DNA over time.
The Role of the MLH1 Gene
The MLH1 gene provides instructions for making a protein that is essential for DNA mismatch repair. During cell division, DNA is copied, and errors can occasionally occur. The MLH1 protein acts as a molecular proofreader, identifying and fixing these mismatched base pairs to ensure the genetic code remains accurate. When the MLH1 gene is functioning correctly, it helps prevent the accumulation of mutations that could lead to uncontrolled cell growth. If the gene is silenced or its expression is significantly reduced, cells may lose their ability to repair these errors, leading to a condition known as microsatellite instability. This instability is a hallmark of Lynch syndrome, a hereditary condition that significantly increases the lifetime risk of developing various cancers, most notably colorectal and endometrial cancers.
Research and Clinical Associations
Research into rs1800795 focuses on its potential to modulate MLH1 expression. While some promoter variants are clearly linked to hereditary cancer syndromes, the clinical significance of rs1800795 is often categorized as requiring further study. Scientific literature has explored whether this variant contributes to the 'second hit' hypothesis, where an inherited predisposition combined with epigenetic changes—such as promoter methylation—leads to gene silencing. Evidence strength for this specific variant is considered moderate, meaning that while associations have been observed in various studies, it is not always a definitive diagnostic marker on its own. Researchers continue to analyze how this variant interacts with other genetic and environmental factors to influence cancer risk, emphasizing that genetic predisposition is complex and rarely determined by a single variant alone.
Population Frequency
The frequency of the rs1800795 variant varies across different global populations. In many large-scale genomic databases, this variant is considered to have a moderate frequency, meaning it is neither extremely rare nor present in the majority of the population. Because genetic diversity is high, the prevalence of specific alleles can differ significantly between ancestral groups. Researchers use this data to better understand the distribution of genetic risk factors and to ensure that clinical studies are representative of diverse populations. If you are interested in your own genetic profile, it is important to remember that population-level statistics describe groups, not individuals, and do not predict personal health outcomes.
Navigating Genetic Information
Information about genetic variants like rs1800795 is intended for educational purposes and should not be used to diagnose or treat any medical condition. If you have concerns about your family history of cancer or your personal risk, the most important step is to consult with a healthcare professional, such as a genetic counselor or an oncologist. They can provide context based on your specific medical history, family background, and clinical testing. Genetic testing results can be complex, and a professional can help you interpret what they mean for your health and what, if any, screening or preventative measures might be appropriate for you. Never make changes to your medical care or screening schedule based solely on information found online.
How common is this variant?
The rs1800795 variant is found at a moderate frequency across diverse global populations, with specific allele distributions varying by ancestry.
Frequently asked questions
Does having the rs1800795 variant mean I have Lynch syndrome?
No, having a specific variant does not equate to a diagnosis of Lynch syndrome. Lynch syndrome is a complex condition typically diagnosed through clinical evaluation, family history, and specialized genetic testing performed by medical professionals.
Can I use this information to change my cancer screening?
You should never change your medical screening or preventative care based on genetic data found online. Always discuss your genetic results with a doctor or genetic counselor who can provide personalized medical advice.
What is the difference between a promoter variant and a gene mutation?
A promoter variant is a change in the regulatory region that controls how much of a protein is made. A gene mutation often refers to a change that alters the protein's structure or function directly.
Where can I find more information about my specific genetic results?
If you have received results from a clinical genetic test, contact the laboratory or the healthcare provider who ordered the test. They are the best resources for interpreting your specific data in the context of your health.
Sources & further reading
Educational information only, last refreshed 10/2/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800795?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29